- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Jeffrey M. Telep (Jeff)
Events 13 results
Webinar
September 9, 2021
14th Annual King & Spalding Medical Device Summit
Webinar
August 26, 2020
Fighting Back Against Medical Product Diversion and Counterfeits in the COVID-19 Era
Speaking Engagement
June 19, 2020
Jeffrey M. Telep to Speak at U.S. Court of Appeals for the Federal Circuit Bench and Bar Conference
Speaking Engagement
November 21, 2019
Jeffrey Telep to Lead International Trade Commission Trial Lawyers Association Annual Meeting
Speaking Engagement
November 18, 2019
Jeffrey Telep to Speak at the 20th Judicial Conference of the U.S. Court of International Trade
Conference
November 15, 2016
9th Annual King & Spalding Pharmaceutical University
Conference
June 9, 2016
King & Spalding Fifth Annual Patent Law Seminar
Conference
May 18, 2016
Tech Law Talks
Webinar
March 10, 2016
King & Spalding e-Learn: TPP: Prospects For Implementation And What TPP Means For Life Sciences Companies
Webinar
August 26, 2015
Combatting Unfair Intellectual Property Practices In International Trade In The Pharmaceutical Industry
Webinar
June 29, 2015
Is International Trade Secret Protection Readily Ascertainable? A Discussion of Issues Related to International
Conference
May 6, 2015
King & Spalding Patent Seminar: A Summary of Recent Developments